TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis

Abdel-Wahab, 2009, Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies, Blood, 114, 144, 10.1182/blood-2009-03-210039 Abdel-Wahab, 2010, Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias, Cancer Res., 70, 447, 10.1158/0008-5472.CAN-09-3783 Beer, 2010, Two routes to leukemic transformation following a JAK2 mutation-positive myeloproliferative neoplasm, Blood, 115, 2891, 10.1182/blood-2009-08-236596 Couronné, 2010, Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias, Leukemia, 24, 201, 10.1038/leu.2009.169 Cozzio, 2003, Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors, Genes Dev., 17, 3029, 10.1101/gad.1143403 Delhommeau, 2009, Mutation in TET2 in myeloid cancers, N. Engl. J. Med., 360, 2289, 10.1056/NEJMoa0810069 Dick, 2008, Stem cell concepts renew cancer research, Blood, 112, 4793, 10.1182/blood-2008-08-077941 Dick, 2009, The role of PLZF in human myeloid development, Ann. N. Y. Acad. Sci., 1176, 150, 10.1111/j.1749-6632.2009.04965.x Figueroa, 2010, Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation, Cancer Cell, 18, 553, 10.1016/j.ccr.2010.11.015 Goardon, 2011, Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia, Cancer Cell, 19, 138, 10.1016/j.ccr.2010.12.012 Huntly, 2004, MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors, Cancer Cell, 6, 587, 10.1016/j.ccr.2004.10.015 Ito, 2010, Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification, Nature, 466, 1129, 10.1038/nature09303 Jaffe, 2009, The 2008 WHO classification of lymphomas: implications for clinical practice and translational research, Hematology Am. Soc. Hematol. Educ. Program, 523, 10.1182/asheducation.V2009.1.523.0010523 Jankowska, 2009, Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms, Blood, 113, 6403, 10.1182/blood-2009-02-205690 Jones, 2010, Functional classification of peripheral T-cell lymphomas as an approach to improve outcome prediction and therapy selection, Semin. Hematol., 47, S1, 10.1053/j.seminhematol.2010.01.013 Ko, 2010, Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2, Nature, 468, 839, 10.1038/nature09586 Ko, 2010, Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2, Nature, 468, 839, 10.1038/nature09586 Kohlmann, 2010, Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1, J. Clin. Oncol., 28, 3858, 10.1200/JCO.2009.27.1361 Koh, 2011, Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells, Cell Stem Cell, 8, 200, 10.1016/j.stem.2011.01.008 Kosmider, 2009, TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs), Blood, 114, 3285, 10.1182/blood-2009-04-215814 Kosmider, 2009, TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia, Haematologica, 94, 1676, 10.3324/haematol.2009.011205 Kriaucionis, 2009, The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain, Science, 324, 929, 10.1126/science.1169786 Langemeijer, 2009, Acquired mutations in TET2 are common in myelodysplastic syndromes, Nat. Genet., 41, 838, 10.1038/ng.391 Ley, 2010, DNMT3A mutations in acute myeloid leukemia, N. Engl. J. Med., 363, 2424, 10.1056/NEJMoa1005143 Nibourel, 2010, Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission, Blood, 116, 1132, 10.1182/blood-2009-07-234484 Saint-Martin, 2009, Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms, Blood, 114, 1628, 10.1182/blood-2009-01-197525 Schaub, 2010, Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms, Blood, 115, 2003, 10.1182/blood-2009-09-245381 Tahiliani, 2009, Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1, Science, 324, 930, 10.1126/science.1170116 Tefferi, 2009, Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates, Leukemia, 23, 900, 10.1038/leu.2009.37 Tefferi, 2009, Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML, Leukemia, 23, 1343, 10.1038/leu.2009.59 Tefferi, 2009, Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML, Leukemia, 23, 1343, 10.1038/leu.2009.59 Tefferi, 2009, TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis, Leukemia, 23, 905, 10.1038/leu.2009.47 Viguié, 2005, Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?, Leukemia, 19, 1411, 10.1038/sj.leu.2403818